RKDA
Arcadia Biosciences
$0.64
−$0.00 (−0.16%)Jul 27, 2026
Key metrics
The numbers that frame RKDA today
- Market cap
- $1.31M
- P/E (TTM)
- -0.1
- EV / FCF
- -0.1
- Gross margin
- 34.5%
- EV / Sales
- 0.1
- ROIC
- -221.3%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $0.59
- 52wk High
- $6.71
Growth
Revenue and earnings trend for RKDA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about RKDA
Is Arcadia Biosciences a good buy?
No. Arcadia Biosciences has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Arcadia Biosciences is selling at a very high price.
What is the market capitalization of RKDA?
Arcadia Biosciences's market capitalization is $1.31M.
What is the P/E ratio for RKDA stock?
Arcadia Biosciences's current P/E ratio is -0.1.
What is the 52-week high for RKDA stock?
The 52-week high for Arcadia Biosciences is $6.71. The current close of $0.64 is 90.5% below that high.
What is the 52-week low for RKDA stock?
The 52-week low for Arcadia Biosciences is $0.59. The current close of $0.64 is 8.3% above that low.
Does RKDA stock pay dividends?
Arcadia Biosciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for RKDA?
Arcadia Biosciences's Debt / Equity ratio is 0.